PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2019-08-06

Date Title Company
06-Aug-2019 Cellular Biomedicine Group Reports Second Quarter and First Half of 2019 Financial Results and Business Highlights Cellular Biomedicine Group
06-Aug-2019 MorphoSys AG Reports Second Quarter 2019 Financial Results (news with additional features) MorphoSys AG
06-Aug-2019 Valens Gears Up For Geographic Expansion With New Offices In Toronto Valens GroWorks Corp.
06-Aug-2019 Jazz Pharmaceuticals Announces Second Quarter 2019 Financial Results Jazz Pharmaceuticals plc
06-Aug-2019 Inovio Closes $15 Million Private Placement of Convertible Bonds to Institutional Investors in Korea Inovio Pharmaceuticals, Inc.
06-Aug-2019 MorphoSys Discloses Biomarker to Stratify Patient Population in B-MIND Study of Tafasitamab plus Bendamustine in r/r DLBCL (news with additional features) MorphoSys AG
06-Aug-2019 MorphoSys Announces Intention to Submit Marketing Authorization Application for Tafasitamab to European Medicines Agency (news with additional features) MorphoSys AG
06-Aug-2019 Rigel Announces Second Quarter 2019 Financial Results and Provides Business Update Rigel Pharmaceuticals, Inc.
06-Aug-2019 Audentes Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update Audentes Therapeutics, Inc.
06-Aug-2019 Curis Reports Second Quarter 2019 Financial Results Curis, Inc.
06-Aug-2019 PTC Therapeutics Reports Second Quarter 2019 Financial Results and Provides a Corporate Update PTC Therapeutics, Inc.
06-Aug-2019 Halozyme Reports Second Quarter 2019 Results Halozyme Therapeutics, Inc.
06-Aug-2019 Statement by Peter Marks, M.D., Ph.D., director of FDA's Center for Biologics Evaluation and Research, on data accuracy issues with recently approved gene therapy U.S. Food and Drug Administration
06-Aug-2019 Sir Gregory Winter FRS to Chair Orion Biotechnology's Scientific Advisory Board Orion Biotechnology
06-Aug-2019 Glauconix Biosciences Announces Appointment of Mrs. Kimberly Southern as Chief Operating Officer Glauconix Biosciences
06-Aug-2019 In Vitro Approach Provides Predictive Platform for Human-Based Drug Discovery TARA Biosystems
06-Aug-2019 Biomarker to avoid safety risk for the sleep deprived The Physiological Society
06-Aug-2019 Dupixent® (dupilumab) showed positive topline results in Phase 3 trial of children aged 6 to 11 years with severe atopic dermatitis Regeneron
06-Aug-2019 Dupixent® (dupilumab) approved by European Commission for adolescents with moderate-to-severe atopic dermatitis Regeneron
06-Aug-2019 Eureka Therapeutics Announces Initiation of Phase 1/2 Clinical Trial of ET140202 ARTEMIS™ T-Cell Therapy in Liver Cancer Eureka Therapeutics